Kantonsspital St.Gallen

Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study

Philipp K A Agyeman, Luregn J Schlapbach, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Matthias Schindler, Insa Korten, Gabriel Konetzny, Anita Niederer-Loher, Christian R. Kahlert, Alex Donas, Antonio Leone, Paul Hasters, Christa Relly, Walter Baer, Claudia E Kuehni, Christoph Aebi, Christoph Berger & Swiss Pediatric Sepsis Study


Sepsis is a leading cause of childhood mortality worldwide. We assessed population-based incidence and outcomes of blood culture-proven bacterial sepsis in children in Switzerland.

We did a multicentre, prospective, cohort study at ten paediatric hospitals in Switzerland. We included neonates and children younger than 17 years with blood culture-proven bacterial sepsis. Children were eligible if they met criteria for systemic inflammatory response syndrome-according to 2005 paediatric consensus definition- at the time of blood culture sampling. Incidence was calculated by dividing the number of annual sepsis episodes in the study for the years 2012-15 by the end-of-year resident paediatric population in Switzerland. The primary outcome was in-hospital mortality in the first 30 days after sepsis onset.

Between Sept 1, 2011, and Dec 31, 2015, we enrolled 1096 children to our study. Of 1181 episodes of blood culture-proven bacterial sepsis, 382 (32%) occurred in 379 previously healthy children, 402 (34%) in 391 neonates, and 397 (34%) in 341 children with comorbidities. Incidence was 25·1 cases per 100 000 (95% CI 23·8-26·4) in children and 146·0 cases per 100 000 (133·2-159·6) in neonates. Central line-associated bloodstream infections and primary bloodstream infections accounted for 569 (48%) of 1181 episodes, and organ dysfunction was present in 455 (39%) of 1181 episodes. Escherichia coli (242 of 1181 [20%]), Staphylococcus aureus (177 of 1181 [15%]), coagulase-negative staphylococci (135 of 1181 [11%]), and Streptococcus pneumoniae (118 of 1181 [10%]) were the most prevalent pathogens in our study, accounting for 57% of episodes. The overall case-fatality ratio was 7% (82 of 1181 episodes; 95% CI 5·6-8·6), and it was higher in neonates (11%, 45 of 402 episodes; 8·4-14·8; adjusted odds ratio [OR] 4·41, 95% CI 1·75-11·1) and children with comorbidities (7%, 27 of 397 episodes; 4·6-9·9; OR 4·97, 1·84-13·4) compared with previously healthy children (3%, ten of 382 episodes; 1·3-4·9). The case-fatality ratio was 1% (five of 726 episodes [95% CI 0·3-1·7]) for children without organ dysfunction, which increased to 17% (77 of 455 episodes [13·7-20·8]) when organ dysfunction was present (adjusted OR 4·84, 95% CI 1·40-16·7).

The burden of blood culture-proven bacterial sepsis on child health remains considerable. We recorded key differences in predominant organisms, severity, and outcome between neonates, previously healthy children, and children with comorbidities. Although for most episodes of blood culture-proven bacterial sepsis, no organ dysfunction was seen, presence of organ dysfunction was strongly associated with mortality.

Swiss National Science Foundation, Swiss Society of Intensive Care, Bangerter Foundation, Vinetum and Borer Foundation, and Foundation for the Health of Children and Adolescents.
citation Agyeman P K A, Schlapbach L J, Giannoni E, Stocker M, Posfay-Barbe K M, Heininger U, Schindler M, Korten I, Konetzny G, Niederer-Loher A, Kahlert C R, Donas A, Leone A, Hasters P, Relly C, Baer W, Kuehni C E, Aebi C, Berger C, Swiss Pediatric Sepsis Study . Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet Child Adolesc Health 2017; 1:124-133.
type journal paper/review (English)
date of publishing 21-07-2017
journal title Lancet Child Adolesc Health (1/2)
ISSN electronic 2352-4650
pages 124-133
PubMed 30169202
DOI 10.1016/S2352-4642(17)30010-X